Skip to main content
鹿得医疗 logo

鹿得医疗 — Investor Relations & Filings

Ticker · 920278 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2022-01-03 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920278

About 鹿得医疗

https://www.asian-medical.com/

Jiangsu Lude Medical Device Co., Ltd. specializes in the research, development, and manufacturing of home medical diagnostic and respiratory care equipment. The company's core product portfolio includes mechanical and electronic sphygmomanometers, stethoscopes, nebulizers, and digital thermometers. It focuses on providing high-precision instruments for chronic disease management and home healthcare. With a strong emphasis on technical innovation and quality control, the firm maintains various international quality certifications to support its global OEM and ODM service capabilities. Its products are designed to meet the needs of both professional medical environments and domestic health monitoring, emphasizing accuracy, reliability, and user-friendly operation in the field of physiological parameter measurement.

Recent filings

Filing Released Lang Actions
方正证券承销保荐有限责任公司关于江苏鹿得医疗电子股份有限公司使用闲置募集资金购买理财产品的核查意见
Regulatory Filings
2022-01-03 Chinese
方正证券承销保荐有限责任公司关于江苏鹿得医疗电子股份有限公司关联交易的专项核查意见
Regulatory Filings
2022-01-03 Chinese
承诺管理制度
Governance Information Classification · 95% confidence The document is a formal announcement from the board of directors of Jiangsu Lude Medical Electronics Co., Ltd. regarding the company's commitment management system. It outlines governance-related rules and procedures for commitments made by controlling shareholders and related parties, referencing relevant laws and company bylaws. The document is not a financial report, earnings release, or a meeting presentation. It is a governance-related disclosure about internal company policies and compliance with regulatory requirements. It does not contain financial data or voting results, nor is it a proxy or remuneration statement. Given the content focuses on governance structure and compliance, the most appropriate classification is Governance Information (CGR). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Confidence is high due to clear governance content and formal board approval.
2022-01-03 Chinese
总经理工作细则
Governance Information Classification · 95% confidence The document is titled '总经理工作细则' which translates to 'General Manager Work Rules' or 'General Manager Operating Procedures'. It outlines the responsibilities, appointment, and duties of the general manager and other senior management personnel, as well as meeting and reporting procedures. There are no financial statements, audit opinions, or financial results presented. The document is a governance-related internal regulation or policy document issued by the company and approved by the board. It does not contain financial data or results, nor is it an announcement of a report. It fits best under governance information as it details the company's internal management structure and governance practices related to senior management roles and responsibilities.
2022-01-03 Chinese
独立董事关于公司第三届董事会第十次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at a board meeting, specifically regarding related party transactions, use of idle raised funds for financial products, and use of excess raised funds to supplement working capital. It includes statements about compliance with laws, company articles, and procedures, and expresses agreement to submit these matters to a shareholders' meeting. The document is a formal opinion or statement from independent directors related to board decisions, not a full report or financial statement. It does not contain financial data or results, nor is it a regulatory announcement or certification. This fits best under Board/Management Information (MANG), which covers announcements of board or management decisions and opinions.
2022-01-03 Chinese
关于红外额头温度计通过美国FDA510(K)审核的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the approval of a medical device (infrared forehead thermometer) by the U.S. FDA under the 510(k) clearance process. It includes details about the product, regulatory classification, and the impact on the company. The document is short (914 characters) and serves as a regulatory announcement about product certification rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-12-09 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.